Alimera Sciences (ALIM) Misses Q1 EPS by 2c

Alimera Sciences (NASDAQ: ALIM) reported Q1 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $9.43 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24